Quality of Hypertension Management in Type 2 Diabetes in India: A Multisite Prescription Audit.

Autor:	Gupta R; Eternal Heart Care Centre and Research Institute, Jaipur, Rajasthan;Corresponding Author., Sharma KK; Fortis Escorts Hospital, Jaipur, Rajasthan., Lodha S; Eternal Heart Care Centre and Research Institute, Jaipur, Rajasthan., Gupta S; Diabetes Care and Research Centre, Nagpur, Maharashtra., Meenawat AS; Satyam Hospital, Jodhpur, Rajasthan., Maheshwari A; BBD College of Dental Sciences, Lucknow, Uttar Pradesh., Mahanta BN; Assam Medical College, Dibrugarh, Assam., Sharma DC; RNT Medical College, Udaipur, Rajasthan., Asirvatham AJ; Madurai Medical College, Madurai, Tamil Nadu., Gupta S; Mahatma Gandhi Medical College, Jaipur, Rajasthan., Sharma SK; Mahatma Gandhi Medical College, Jaipur, Rajasthan.
Jazyk:	angličtina
Zdroj:	The Journal of the Association of Physicians of India [J Assoc Physicians India] 2018 Sep; Vol. 66 (9), pp. 20-25.
Abstrakt:	Background and Objective: Renin-angiotensin system (RAS) blockers (angiotensin converting enzyme inhibitors ACEI, angiotensin receptor blockers, ARB) are preferred drugs to control hypertension among diabetic patients. To determine frequency of RAS blocker use in hypertensive patients with type 2 diabetes, we performed a multisite study in India. Methods: We evaluated physician prescriptions in consecutive patients with type 2 diabetes at 9 sites in India. Details of socio-demographic characteristics, clinical findings and prescription medicines were obtained. Descriptive statistics are reported. Results: Hypertension treatment details were available in 8056 of 8699 diabetic patients (4829 men, 3227 women). No hypertension was in 3300 (40.9%), hypertension in 3625 (45.0%), and hypertension with vascular disease in 1131 (14.0%). In diabetics with no hypertension, hypertension, and hypertension with vascular disease, respectively, prescriptions of antihypertensive drugs was: RAS blockers in 19.4, 48.2 and 58.1%, beta-blockers in 4.8, 31.6 and 38.8%, calcium channel blockers in 0.4, 27.4 and 14.3% and diuretics in 0.6, 36.4 and 17.1%. ACEIs were prescribed more frequently than ARB's in hypertensive diabetics (60.7 vs 39.2%) as well as in diabetics with vascular disease (58.6 vs 41.4%). In diabetics with hypertension (n=3625) prescription of one, two or three antihypertensive drugs was 49.8%, 33.7% and 3.5% while statins were prescribed in 54.1%. Conclusion: Use of RAS blockers (ACEI or ARB) in uncomplicated as well as complicated hypertensive patients with type 2 diabetes is sub-optimal. Most of the patients are on one drug and prescription of ≥3 drugs are rare. Statins are prescribed in only a half. (© Journal of the Association of Physicians of India 2011.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu